Science news articles about 'joslin diabetes center boston'
Researchers describe protease inhibitor that may aid in diabetic retinopathy treatment
Researchers from Joslin Diabetes Center, Boston, and ActiveSite Pharmaceuticals, Inc., San Francisco, announced today that they have demonstrated that a specific inhibitor of the protease plasma ...